Literature DB >> 2661682

Infection control: opportunistic fungal infections--the increasing importance of Candida species.

M A Pfaller1.   

Abstract

Candida spp are clearly among the most important of the opportunistic fungal pathogens that cause nosocomial infections. Given the increasing incidence, high attributable mortality and excess length of stay associated with nosocomial candidemia, it is imperative that more effective preventive, diagnostic and therapeutic measures be developed to deal with this emerging group of pathogens. Implicit in these issues is the need for an increased understanding of the epidemiology of nosocomial candidiasis. The development of new epidemiologic typing methods provides useful tools that can assist in clinical and epidemiologic investigation. These studies are essential to the rational development of effective measures to prevent and to control nosocomial infections caused by Candida spp.

Entities:  

Mesh:

Year:  1989        PMID: 2661682     DOI: 10.1086/646021

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  11 in total

1.  Standardized susceptibility testing of fluconazole: an international collaborative study.

Authors:  M A Pfaller; B Dupont; G S Kobayashi; J Müller; M G Rinaldi; A Espinel-Ingroff; S Shadomy; P F Troke; T J Walsh; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Comparison of restriction enzyme analysis and pulsed-field gradient gel electrophoresis as typing systems for Candida albicans.

Authors:  J A Vazquez; A Beckley; J D Sobel; M J Zervos
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Chronic urinary tract infection due to Candida utilis.

Authors:  K C Hazen; G W Theisz; S A Howell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

4.  Typing and nosocomial candidiasis.

Authors:  C Maffei; E Manso; F Biavasco; P E Varaldo; M L Moro
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 5.  Epidemiology, therapy and costs of nosocomial infection.

Authors:  R Gálvez-Vargas; A Bueno-Cavanillas; M García-Martín
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

Review 6.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  In vitro activity of a new polyene, SPA-S-843, against yeasts.

Authors:  C Rimaroli; T Bruzzese
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

8.  Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.

Authors:  L Maródi; S Schreiber; D C Anderson; R P MacDermott; H M Korchak; R B Johnston
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

Review 9.  Impact of the changing epidemiology of fungal infections in the 1990s.

Authors:  M Pfaller; R Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

10.  Evaluation of pulsed-field gel electrophoresis as a typing system for Candida rugosa: comparison of karyotype and restriction fragment length polymorphisms.

Authors:  J C Dib; M Dube; C Kelly; M G Rinaldi; J E Patterson
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.